Article History
Accepted: 16 April 2021
First Online: 21 May 2021
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Nicholas Stefanovic has nothing to disclose.Alan D. Irvine reports and Consultancy- AbbVie, Arena Pharmaceuticals, BenevolentAI, Chugai, Dermavant, Genentech, LEO Pharma, Lilly, Menlo Therapeutics, Novartis, Pfizer, Regeneron, Sanofi, and UCB..Carsten Flohr is chief investigator of the UK National Institute for Health Research-funded TREAT (ISRCTN15837754) and SOFTER (ExternalRef removed: NCT03270566) trials as well as the UK-Irish Atopic eczema Systemic Therapy Register (A-STAR; ISRCTN11210918) and a principal investigator in the European Union Horizon 2020-funded BIOMAP Consortium (ExternalRef removed). His department has also received funding from Sanofi-Genzyme.
: This article does not contain any studies with human or animal subjects performed by any of the authors.